{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:18:57Z","timestamp":1787505537647,"version":"build-2736575974"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hormone receptor\u2010positive (HR+), HER2\u2010negative (HER2\u2212) breast cancer represents the most common subtype. Given its distinct biology, neoadjuvant endocrine therapy (NET) offers comparable efficacy to neoadjuvant chemotherapy (NCT) with less toxicity. This systematic review and network meta\u2010analysis evaluates the evidence to guide clinical decision\u2010making for locally advanced or inoperable HR+\/HER2\u2212 breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed phase II\/III neoadjuvant clinical trials in HR+\/HER2\u2212 breast cancer. Primary endpoints were overall response rate (ORR) by palpation and imaging. Secondary endpoints included breast\u2010conserving surgery (BCS) rates, pathological complete response (pCR), and safety. Treatment efficacy was ranked using surface under the cumulative ranking curve (SUCRA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5181 patients across 21 trials were included in the study. CDK4\/6 inhibitor + ET ranked highest for ORR by palpation (90.9%), and BCS (77.1%), followed by aromatase inhibitors (76.1% and 74.4%, respectively). For ORR by radiography, chemotherapy ranked first (87.6%) followed by the tyrosine kinase inhibitor (TKI) plus ET (76.7%). TKI\u2009+\u2009ET ranked first in pCR (79.6%), followed by chemotherapy (76.1%). Selective estrogen receptor degraders were the most tolerable, with the highest ranking in completion rate (84.1%) and fewer \u2265\u2009grade 3 adverse events (90.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NET is a viable alternative to NCT in HR+\/HER2\u2212 patients. CDK4\/6\u2009+\u2009ET demonstrates superior tumor reduction and safety, potentially enabling postoperative therapy de\u2010escalation. These findings support NET as a strategic option for optimizing outcomes while minimizing toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cam4.71648","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:42:11Z","timestamp":1770975731000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beyond Chemotherapy: Network Meta\u2010Analysis Reveals Optimal Neoadjuvant Strategies for Luminal Breast Cancer"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2989-1036","authenticated-orcid":false,"given":"Xinyu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijing","family":"Du","sequence":"additional","affiliation":[{"name":"Ningxia Medical University  Yinchuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-8621","authenticated-orcid":false,"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076834"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121255"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01393-6"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.6155"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30292-4"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607303"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00144"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00435"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0916"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-066381","article-title":"Evaluation of Pathological Complete Response as Surrogate Endpoint in Neoadjuvant Randomised Clinical Trials of Early Stage Breast Cancer: Systematic Review and Meta\u2010Analysis","volume":"375","author":"Conforti F.","year":"2021","journal-title":"BMJ"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8595"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3492"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn309"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201846"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2015.07.019"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01314-6"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.1897"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1188"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01624"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy448"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30786-7"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.505"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04588-3"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013128213451"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.005"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21872"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70373-4"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.6038"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01288-5"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22789"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.23.16_suppl.530"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30334-1"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103100"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS22-P3-07-07"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds132"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.6578"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4737"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3183-4"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30143"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0627"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1425"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.03.010"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186479"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092077"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.6950"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0795-4"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102670"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758834017711097"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.009"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00338"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.017"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02759"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.71648","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.71648","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.71648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:27:52Z","timestamp":1786703272000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.71648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/cam4.71648"],"URL":"https:\/\/doi.org\/10.1002\/cam4.71648","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"2025-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71648"}}